Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX)

CUSIP: 09203E105

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
58,000,000
Total 13F shares
46,760,739
Share change
+7,336,803
Total reported value
$217,913,327
Put/Call ratio
40%
Price per share
$4.66
Number of holders
88
Value change
+$31,657,196
Number of buys
55
Number of sells
46

Quarterly Holders Quick Answers

What is CUSIP 09203E105?
CUSIP 09203E105 identifies BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Bellevue Group AG
13F
Company
15%
8,517,839
$43,185,444 31 Mar 2024
13F
T. Rowe Price Investment Management, Inc.
13F
Company
12%
6,725,365
$34,098,000 31 Mar 2024
13F
NEA Management Company, LLC
13F
Company
7.7%
4,448,757
$22,555,198 31 Mar 2024
13F
RA CAPITAL MANAGEMENT, L.P.
13F 3/4/5
Company · Director
6.1%
3,525,754
$17,875,573 31 Mar 2024
VANGUARD GROUP INC
13F
Company
3.3%
1,905,300
$9,659,871 31 Mar 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
2.8%
1,603,200
$8,128,224 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
2.4%
1,380,522
$6,999,246 31 Mar 2024
13F
Artal Group S.A.
13F
Company
1.8%
1,046,517
$5,305,841 31 Mar 2024
13F
Laurion Capital Management LP
13F
Company
1.5%
878,286
$4,452,910 31 Mar 2024
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
1.2%
717,183
$3,636,118 31 Mar 2024
13F
Blue Owl Capital Holdings LP
13F
Company
1.2%
695,000
$3,523,650 31 Mar 2024
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1%
605,901
$3,071,918 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.94%
546,237
$2,769,422 31 Mar 2024
13F
Boxer Capital, LLC
13F
Company
0.87%
506,000
$2,565,420 31 Mar 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.73%
423,923
$2,149,290 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.66%
382,613
$1,940,313 31 Mar 2024
13F
David M. Epstein
3/4/5
Officer Title: President and Chief Executive Officer, Director
class O/S missing
688,002
$1,878,246 27 Jun 2023
TWO SIGMA INVESTMENTS, LP
13F
Company
0.62%
358,064
$1,815,384 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.57%
333,248
$1,689,567 31 Mar 2024
13F
Verition Fund Management LLC
13F
Company
0.57%
328,906
$1,667,553 31 Mar 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.54%
314,502
$1,594,525 31 Mar 2024
13F
BIT Capital GmbH
13F
Company
0.47%
275,307
$1,395,806 31 Mar 2024
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.44%
257,000
$1,302,990 31 Mar 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.43%
250,555
$1,270,314 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.37%
212,600
$1,078,000 31 Mar 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.3%
173,000
$877,110 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.3%
172,629
$875,229 31 Mar 2024
13F
Squarepoint Ops LLC
13F
Company
0.3%
171,376
$868,876 31 Mar 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.29%
170,510
$864,000 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.29%
167,246
$847,937 31 Mar 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.29%
165,686
$840,028 31 Mar 2024
13F
STIFEL FINANCIAL CORP
13F
Company
0.26%
148,300
$751,881 31 Mar 2024
13F
HRT FINANCIAL LP
13F
Company
0.22%
125,094
$634,000 31 Mar 2024
13F
Newtyn Management, LLC
13F
Company
0.22%
125,000
$633,750 31 Mar 2024
13F
Man Group plc
13F
Company
0.21%
119,460
$605,662 31 Mar 2024
13F
STATE STREET CORP
13F
Company
0.2%
117,084
$593,616 31 Mar 2024
13F
ExodusPoint Capital Management, LP
13F
Company
0.2%
115,576
$586,000 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0.19%
112,451
$570,127 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.19%
111,666
$566,147 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.18%
104,032
$527,442 31 Mar 2024
13F
FOUNDATIONS INVESTMENT ADVISORS, LLC
13F
Company
0.17%
96,500
$489,255 31 Mar 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.17%
96,300
$488,241 31 Mar 2024
13F
Marathon Trading Investment Management LLC
13F
Company
0.16%
94,400
$478,608 31 Mar 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.12%
70,848
$359,199 31 Mar 2024
13F
Castleview Partners, LLC
13F
Company
0.11%
63,866
$323,800 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.1%
58,898
$298,613 31 Mar 2024
13F
CORNERCAP INVESTMENT COUNSEL INC
13F
Company
0.08%
48,629
$246,549 31 Mar 2024
13F
Cubist Systematic Strategies, LLC
13F
Company
0.08%
43,699
$221,554 31 Mar 2024
13F
Jump Financial, LLC
13F
Company
0.07%
38,468
$195,033 31 Mar 2024
13F
Point72 Asia (Singapore) Pte. Ltd.
13F
Company
0.06%
37,145
$188,325 31 Mar 2024
13F

Institutional Holders of Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX) as of Q2 2024

As of 30 Jun 2024, Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,760,739 shares. The largest 10 holders included T. Rowe Price Investment Management, Inc., Bellevue Group AG, NEA Management Company, LLC, BlackRock Inc., VANGUARD GROUP INC, Vestal Point Capital, LP, TANG CAPITAL MANAGEMENT LLC, Artal Group S.A., MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 88 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
86
Q2 2024 holders
88
Holder diff
2
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .